DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Bajetta E, Di Bartolomeo M, Marian L. et al.
Randomized multicenter Phase II trial of two different schedules of irinotecan combined with capecitabine as first line treatment in metastatic colorectal carcinoma.
Cancer 2004; 100: 279-287
We do not assume any responsibility for the contents of the web pages of other providers.